Autor(en) Titel Quelle Links
Faivre L, Meerpohl J, Da Costa L, Marie I, Nouvel C, Gnekow A, Bender-Götze C, Bauters F, Coiffier B, Peaud PY, Rispal P, Berrebi A, Berger C, Flesch M, Sagot P, Varet B, Niemeyer C, Tchernia G, Leblanc T High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries. [+] Haematologica 2006, 91: 530  
Fanconi G Familiäre infantile perniziosaartige Anämie (perniziöses Blutbild und Konstitution). Jahrb Kinderheilk 1927,: 257  
Fanconi G Familial constitutional panmyelocytopathy, Fanconi's anemia (F. A.). I. Clinical aspects. Semin Hematol 1967, 4: 233  
Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 1997, 80: 2156  
Farahati J, Parlowsky T, Mader U, Reiners C, Bucsky P Differentiated thyroid cancer in children and adolescents. Langenbecks Arch Surg 1998, 383: 235  
Farrar JE, Vlachos A, Atsidaftos E, Carlson-Donohoe H, Markello TC, Arceci RJ, Ellis SR, Lipton JM, Bodine DM Ribosomal protein gene deletions in Diamond-Blackfan anemia. [+] Blood 2011, 118: 6943  
Fasano RM, Meier ER, Hulbert ML Cerebral vasculopathy in children with sickle cell anemia. [+] Blood cells, molecules & diseases 2015, 54: 17  
Favrot M, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group. Ann Oncol 1996, 7: 607  
Favara B, Feller A, Pauli M, Jaffe E, Weiss L, Arico M, Bucsky P, Egeler R, Elinder G, Gadner H, Gresik M, Henter J, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997, 29: 157  
Fazekas T, Eickhoff P, Lawitschka A, Knotek B, Pötschger U, Peters C Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation. [+] European journal of pediatrics 2012 Feb 16;  
Fazekas T, Attarbaschi A, Lawitschka A, Seidel M, Pötschger U, Peters C, Mann G, Gadner H, Matthes-Martin S Lethal pulmonary complications after pediatric allogeneic hematopoietic stem cell transplantation. [+] The Pediatric infectious disease journal 2012, 31: 115  
Fengler R, Baumgarten E, Buchmann S, Creutzig U, Harbott J, Ludwig R, Henze G Biklonale Leukämie (O-ALL/AMoL) mit 11;19 Translokation und Trisomie X bei einem 8 Monate alten Mädchen. Klinische Pädiatrie 1986, 198: 178  
Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. [+] Blood 1999 Aug 15; 94: 1192  
Ferrari A, Casanova M, Bisogno G, Mattke A, Meazza C, Gronchi A, Cecchetto G, Fidani P, Kunz D, Treuner J, Carli M Hemangiopericytoma in pediatric ages. Cancer 2001, 92: 2692  
Ferris Tortajada J, Garcia Castell J, Berbel Tornero O, Clar Gimeno S Risk factors for non-Hodgkin’s lymphomas. An Esp Pediatr 2001, 55: 230  
Ferris Tortajada J, Garcia Castell J, Lopez Andreu JA, Clar Gimeno S, Berbel Tornero O Risk factors for Hodgkin's lymphomas. An Esp Pediatr 2001, 55: 239  
Ferrari A, Bisogno G, Casanova M, Meazza C, Piva L, Cecchetto G, Zanetti I, Pilz T, Mattke A, Treuner J, Carli M Paratesticular rhabdomyosarcoma. J Clin Oncol 2002, 20: 449  
Ferrari A, Casanova M, Bisogno G, Cecchetto G, Meazza C, Gandola L, Garaventa A, Mattke A, Treuner J, Carli M Malignant vascular tumors in children and adolescents. Med Pediatr Oncol 2002, 39: 109  
Ferrari A, Casanova M, Bisogno G, Mattke A, Meazza C, Gandola L, Sotti G, Cecchetto G, Harms D, Koscielniak E, Treuner J, Carli M Clear cell sarcoma of tendons and aponeuroses in pediatric patients. Cancer 2002, 94: 3269  
Ferrari A, Bisogno G, Casanova M, Brecht I, Alaggio R, Cecchetto G, Provenzi M, Koscielniak E, Treuner J, Carli M Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? Pediatr Blood Cancer 2004, 42: 134  
Ferrari A, Casanova M, Bisogno G, Carli M, Treuner J What chemotherapy should alveolar paratesticular rhabdomyosarcoma receive? Pediatr Blood Cancer 2004, 43: 295  
Ferrari A, Brecht IB, Koscielniak E, Casanova M, Scagnellato A, Bisogno G, Alaggio R, Cecchetto G, Catania S, Meazza C, Int-Veen C, Kirsch S, Dantonello T, Carli M, Treuner J The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas. [+] Pediatric blood & cancer 2005, 45: 128  
Ferrari A, Bisogno G, De Salvo GL, Indolfi P, Perilongo G, Cecchetto G, Italian Study on Rare Tumours in Paediatric Age (TREP),Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) The challenge of very rare tumours in childhood: the Italian TREP project. [+] European journal of cancer 2007, 43: 654  
Ferrari A, Schneider DT, Bisogno G, EXPeRT Board The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT. Expert review of anticancer therapy 2013, 13: 1  
Lê PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. [+] Pediatric blood & cancer 2015, 62: 1956  
Feuchtinger T Susceptibility to childhood leukemia. Blood 2011 118: 1189  
Fichtner I, Lemm M, Becker M, Berthold F Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas. Anticancer Drugs 1997, 8: 174  
Fichtner I, Paal K, Borgmann A, Badiali L, Wurm R, Henze G Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins. Anticancer Res 2003, 23: 2657  
Filipovich AH, Mathur A, Kamat D, Shapiro RS Primary inmunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992, 52: 5465  
Filipovich AH Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. [+] Pediatric transplantation 2005, 9 Suppl 7: 87  
Finger PT, Czechonska G, Demirci H, Rausen A Chemotherapy for retinoblastoma: a current topic. [+] Drugs 1999, 58: 983  
Fine B, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer L Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004, 103: 1043  
Fischer M, Berthold F Characterization of the gene expression profile of neuroblastoma cell line IMR-5 using serial analysis of gene expression. Cancer Lett 2003, 190: 79  
Fischer M, Skowron M, Berthold F Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA. [+] The Journal of molecular diagnostics 2005, 7: 89  
Fischer M, Oberthuer A, Brors B, Kahlert Y, Skowron M, Voth H, Warnat P, Ernestus K, Hero B, Berthold F Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome. [+] Clinical cancer research : an official journal of the American Association for Cancer Research 2006, 12: 5118  
Fischer M, Spitz R, Oberthür A, Westermann F, Berthold F Risk estimation of neuroblastoma patients using molecular markers. [+] Klinische Padiatrie 2008, 220: 137  
Fischer M, Bauer T, Oberthür A, Hero B, Theissen J, Ehrich M, Spitz R, Eils R, Westermann F, Brors B, König R, Berthold F Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q. [+] Oncogene 2010, 29: 865  
Fischer M, Berthold F The role of complex genomic alterations in neuroblastoma risk estimation. [+] Genome medicine 2010 May 19; 2: 31  
Flentje M, Weirich A, Potter R, Ludwig R Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH. Radiother Oncol 1994, 31: 222  
Flentje M, Weirich A, Graf N, Potter R, Zimmerman H, Ludwig R Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. Int J Radiat Oncol Biol Phys 1998, 40: 163  
Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J Lifetime risks of common cancers among retinoblastoma survivors. [+] Journal of the National Cancer Institute 2004, 96: 357  
Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J, Hasle H, Arico M, Biondi A, Niemeyer C RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999, 13: 32  
Flower KB, Hoppin JA, Lynch CF, Blair A, Knott C, Shore DL, Sandler DP Cancer risk and parental pesticide application in children of Agricultural Health Study participants. Environ Health Perspect 2004, 112: 631  
Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S, Stanulla M, Basso G, Niggli FK, Schäfer BW, Sutton R, Koehler R, Zimmermann M, Valsecchi MG, Gadner H, Masera G, Schrappe M, van Dongen JJ, Biondi A, Bartram CR, International BFM Study Group (I-BFM-SG) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. [+] Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008, 22: 771  
Flotho C, Vraetz T, Lang P, Niemeyer CM, Strahm B Successful double umbilical cord blood transplantation for relapsed juvenile myelomonocytic leukemia. Leukemia 2013, 27: 988  
Fluss J, Dinomais M, Kossorotoff M, Vuillerot C, Darteyre S, Chabrier S Perspectives in neonatal and childhood arterial ischemic stroke. Expert review of neurotherapeutics 2017, 17: 135  
Foell JL, Max D, Giersberg C, Körholz D, Staege MS Sensitivity of Hodgkin's lymphoma cell lines to the cell cycle inhibitor roscovitine. [+] Anticancer research 2008, 28: 887  
Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E, Corbacioglu S Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study. Bone marrow transplantation 2017, 52: 938  
Foulon S, Brennan B, Gaspar N, Dirksen U, Jeys L, Cassoni A, Claude L, Seddon B, Marec-Berard P, Whelan J, Paulussen M, Streitbuerger A, Oberlin O, Jürgens H, Grimer R, Le Deley MC Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E. W.I. N.G group. [+] European journal of cancer 2016, 61: 128  
Franzius C, Bielack S, Sciuk J, Vollet B, Jürgens H, Schober O High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma. Nuklearmedizin 1999, 38: 337  
Franzius C, Sciuk J, Brinkschmidt C, Jürgens H, Schober O Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clinical Nuclear Medicine 2000, 25: 874  
Franzius C, Sciuk J, Daldrup-Link H, Jürgens H, Schober O FDG-PET for detection of osseous metastases from malignant primary bone tumors. Eur J Nucl Med 2000, 27: 1305  
Franzius C, Daldrup-Link H, Sciuk J, Rummeny E, Bielack S, Jürgens H, Schober O FDG-PET for detection of pulmonary metastases from malignant primary bone tumors. Ann Oncol 2001, 12: 479  
Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O Klinische Wertigkeit der Positronenemissionstomographie (PET) in der Diagnostik der Knochen- und Weichteiltumore. Chirurg 2001, 72: 1071  
Franzius C, Bielack S, Flege S, Sciuk J, Jürgens H, Schober O Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 2002, 43: 1012  
Franzius C, Daldrup-Link H, Wagner-Bohn A, Sciuk J, Heindel W, Jürgens H, Schober O FDG-PET for detection of recurrences from malignant primary bone tumors. Ann Oncol 2002, 13: 157  
Franzius C, Schuck A, Bielack S High-dose samarium-153 ethylene diamine tetramethylene phosphonate. J Clin Oncol 2002, 20: 1953  
Franzius C, Hotfilder M, Poremba C, Hermann S, Schafers K, Gabbert HE, Jürgens H, Schober O, Schafers M, Vormoor J Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model. [+] European journal of nuclear medicine and molecular imaging 2006, 33: 1432  
Franzius C, Juergens KU, Vormoor J PET/CT with diagnostic CT in the evaluation of childhood sarcoma. AJR. American journal of roentgenology 2006, 186: 581; author reply 581  
Franke M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group. [+] Pediatr Blood Cancer 2011, 56: 771  
Franke M, Hardes J, Helmke K, Jundt G, Jürgens H, Kempf-Bielack B, Kevric M, Tunn PU, Werner M, Bielack S Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group. [+] Pediatric blood & cancer 2011, 56: 771  
Freidank C Wegweiser für zu Hause. Leitung der bundesweiten Arbeitsgruppe pädiatrisch-onkologischer Kinderkrankenschwestern und Kinderkrankenpfleger (GPONG: German Pediatric Oncology Nurses Group) 2002  
Friedman JM, Birch PH Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997, 70: 138  
Friesen C, Fulda S, Debatin K Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 1999, 6: 471  
Friedrich C, von Bueren AO, von Hoff K, Gerber NU, Ottensmeier H, Deinlein F, Benesch M, Kwiecien R, Pietsch T, Warmuth-Metz M, Faldum A, Kuehl J, Kortmann RD, Rutkowski S Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. [+] Neuro-oncology 2013, 15: 224  
Friedrich C, Warmuth-Metz M, von Bueren AO, Nowak J, Bison B, von Hoff K, Pietsch T, Kortmann RD, Rutkowski S Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease. [+] Journal of neurosurgery. Pediatrics 2015, 1  
Friedrich C, Shalaby T, Oehler C, Pruschy M, Seifert B, Picard D, Remke M, Warmuth-Metz M, Kortmann RD, Rutkowski S, Grotzer MA, von Bueren AO Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2017, 33: 1463  
Frömmel C, Brose A, Klein J, Blankenstein O, Lobitz S Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants. [+] BioMed research international 2014, 2014, 695828  
Frühwald MC, Graf N Rhabdoide Tumoren im Kindesalter - Einheitliches Konzept für die Behandlung von Tumoren des Gehirns, der Nieren und des Weichgewebes. WIR - Informationsschrift der Aktion für krebskranke Kinder e.V. des Dachverbandes Deutsche Leukämie-Forschungshilfe 4/2006  
Frühwald MC, Krefeld B, Benesch M, Büchner J, Boos J, Ebetsberger G, Graf N, Kortmann R, Nysom K, Rutkowski S, Schneppenheim R, Siebert R, Timmermann B, Warmuth-Matz M, Hasselblatt M The European Rhabdoid Registry (EU-RHAB) – A comprehensive approach towards biology and clinical management. [+] Neurooncology 2010, 12:ii36  
Frühwald MC, Rutkowski S ZNS-Tumoren bei Kindern und Jugendlichen. Dtsch Arztebl Int 2011; 108: 390  
Fröhlich B, Hotzinger H, Fritsch H Tomographical anatomy of the pelvis, pelvic floor, and related structures. Clin Anat 1997, 10: 223  
Fröhlich B, Ahrens S, Burdach S, Klingebiel T, Ladenstein R, Paulussen M, Zoubek A, Jürgens H High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS. Klin Pädiatr 1999, 211: 284  
Fuchs N, Winkler K Osteosarcoma. Curr Opin Oncol 1993, 5: 667  
Fuchs J, Wenderoth M, von Schweinitz D, Haindl J, Leuschner I Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Cancer 1998, 83: 2400  
Fuchs N, Bielack S, Epler D, Bieling P, Delling G, Körholz D, Graf N, Heise U, Jürgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998, 9: 893  
Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma. Klin Pädiatr 1999, 211: 305  
Fuchs J, Rydzynski J, von Schweinitz D, Bode U, Hecker H, Weinel P, Burger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H Pretreatment prognostic factors and treatment results in children with hepatoblastoma. Cancer 2002, 95: 172  
Fulda S, Honer M, Menke-Moellers I, Berthold F Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro. Eur J Cancer 1995, 31A: 616  
Fulda S, Susin S, Kroemer G, Debatin K Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 1998, 58: 4453  
Fulda S, Jeremias I, Pietsch T, Debatin K Betulinic acid. Klin Pädiatr 1999, 211: 319  
Fulda S, Jeremias I, Steiner H, Pietsch T, Debatin K Betulinic acid. Int J Cancer 1999, 82: 435  
Fulda S, Lutz W, Schwab M, Debatin K MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene 1999, 18: 1479  
Fulda S, Meyer E, Debatin K Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000, 60: 3947  
Furlan I, Batz C, Flotho C, Mohr B, Lübbert M, Suttorp M, Niemeyer CM Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood 2009, 113: 2867  
Furtwängler R, Nourkami N, Alkassar M, von Schweinitz D, Schenk JP, Rübe C, Siemer S, Leuschner I, Graf N Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group. [+] Klin padiatr 2011, 223: 113  
Furtwängler R, Gooskens SL, van Tinteren H, de Kraker J, Schleiermacher G, Bergeron C, de Camargo B, Acha T, Godzinski J, Sandstedt B, Leuschner I, Vujanic GM, Pieters R, Graf N, van den Heuvel-Eibrink MM Clear Cell Sarcomas of the Kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: A report of the SIOP Renal Tumour Study Group. [+] European journal of cancer (Oxford, England : 1990) 2013, epub ahead of print  
Furtwängler R, Schmolze M, Gräber S, Leuschner I, Amann G, Schenk JP, Niggli F, Kager L, von Schweinitz D, Graf N Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma. [+] Klinische Padiatrie 2014, 226: 175  
Futaki M, Yamashita T, Yagasaki H, Toda T, Yabe M, Kato S, Asano S, Nakahata T The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. [+] Blood 2000, 95: 1493  
89 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.